InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Monday, 05/03/2010 9:21:49 AM

Monday, May 03, 2010 9:21:49 AM

Post# of 392
Biotech Busts And Breakthroughs

The markets keep getting tougher. Vanda Pharmaceuticals ( VNDA - news - people ), (its 20% decline during the month puts it second-to-worst on our losers list) is facing an unsuccessful launch of its schizophrenia drug Fanapt, according to Madison Willliams analyst David Moskowitz. Merck's ( MRK - news - people ) new entrant, Saphris, is soaking up all the demand, while Novartis ( NVS - news - people ), which markets Fanapt, seems to be putting little weight behind the product.


http://www.forbes.com/2010/05/01/biotech-busts-breakthroughs-business-healthcare-april-2010.html?partner=yahootix


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNDA News